Literature DB >> 27815748

A model for individualized risk prediction of contralateral breast cancer.

Marzana Chowdhury1, David Euhus2, Tracy Onega3, Swati Biswas4, Pankaj K Choudhary5.   

Abstract

PURPOSE: Patients diagnosed with invasive breast cancer (BC) or ductal carcinoma in situ are increasingly choosing to undergo contralateral prophylactic mastectomy (CPM) to reduce their risk of contralateral BC (CBC). This is a particularly disturbing trend as a large proportion of these CPMs are believed to be medically unnecessary. Many BC patients tend to substantially overestimate their CBC risk. Thus, there is a pressing need to educate patients effectively on their CBC risk. We develop a CBC risk prediction model to aid physicians in this task.
METHODS: We used data from two sources: Breast Cancer Surveillance Consortium and Surveillance, Epidemiology, and End Results to build the model. The model building steps are similar to those used in developing the BC risk assessment tool (popularly known as Gail model) for counseling women on their BC risk. Our model, named CBCRisk, is exclusively designed for counseling women diagnosed with unilateral BC on the risk of developing CBC.
RESULTS: We identified eight factors to be significantly associated with CBC-age at first BC diagnosis, anti-estrogen therapy, family history of BC, high-risk pre-neoplasia status, estrogen receptor status, breast density, type of first BC, and age at first birth. Combining the relative risk estimates with the relevant hazard rates, CBCRisk projects absolute risk of developing CBC over a given period.
CONCLUSIONS: By providing individualized CBC risk estimates, CBCRisk may help in counseling of BC patients. In turn, this may potentially help alleviate the rate of medically unnecessary CPMs.

Entities:  

Keywords:  Absolute risk; Breast Cancer Surveillance Consortium; Breast density; CBCRisk; Contralateral breast cancer; SEER

Mesh:

Year:  2016        PMID: 27815748      PMCID: PMC5224985          DOI: 10.1007/s10549-016-4039-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.624


  42 in total

1.  Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer.

Authors:  Judy C Boughey; Tanya L Hoskin; Amy C Degnim; Thomas A Sellers; Joanne L Johnson; Melanie J Kasner; Lynn C Hartmann; Marlene H Frost
Journal:  Ann Surg Oncol       Date:  2010-09-19       Impact factor: 5.344

2.  Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.

Authors:  Tari A King; Rita Sakr; Sujata Patil; Inga Gurevich; Michelle Stempel; Michelle Sampson; Monica Morrow
Journal:  J Clin Oncol       Date:  2011-04-04       Impact factor: 44.544

3.  Bilateral prophylactic mastectomy in women with inherited risk of breast cancer--prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery.

Authors:  Jessica Gahm; Marie Wickman; Yvonne Brandberg
Journal:  Breast       Date:  2010-06-03       Impact factor: 4.380

Review 4.  Prophylactic mastectomy for the prevention of breast cancer.

Authors:  Liz Lostumbo; Nora E Carbine; Judi Wallace
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

5.  Women's regrets after bilateral prophylactic mastectomy.

Authors:  D K Payne; C Biggs; K N Tran; P I Borgen; M J Massie
Journal:  Ann Surg Oncol       Date:  2000-03       Impact factor: 5.344

6.  Prevalence of and factors associated with persistent pain following breast cancer surgery.

Authors:  Rune Gärtner; Maj-Britt Jensen; Jeanette Nielsen; Marianne Ewertz; Niels Kroman; Henrik Kehlet
Journal:  JAMA       Date:  2009-11-11       Impact factor: 56.272

7.  Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study.

Authors:  Lisbeth Bertelsen; Leslie Bernstein; Jørgen H Olsen; Lene Mellemkjaer; Robert W Haile; Charles F Lynch; Kathleen E Malone; Hoda Anton-Culver; Jane Christensen; Bryan Langholz; Duncan C Thomas; Colin B Begg; Marinela Capanu; Bent Ejlertsen; Marilyn Stovall; John D Boice; Roy E Shore; Jonine L Bernstein
Journal:  J Natl Cancer Inst       Date:  2007-12-25       Impact factor: 13.506

8.  Simplifying clinical use of the genetic risk prediction model BRCAPRO.

Authors:  Swati Biswas; Philamer Atienza; Jonathan Chipman; Kevin Hughes; Angelica M Gutierrez Barrera; Christopher I Amos; Banu Arun; Giovanni Parmigiani
Journal:  Breast Cancer Res Treat       Date:  2013-05-21       Impact factor: 4.872

Review 9.  Contralateral risk-reducing mastectomy in sporadic breast cancer.

Authors:  John A Murphy; Thomas D Milner; Joseph M O'Donoghue
Journal:  Lancet Oncol       Date:  2013-06       Impact factor: 41.316

10.  Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening.

Authors:  Nehmat Houssami; Linn A Abraham; Karla Kerlikowske; Diana S M Buist; Les Irwig; Janie Lee; Diana L Miglioretti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-19       Impact factor: 4.254

View more
  12 in total

Review 1.  A review of the influence of mammographic density on breast cancer clinical and pathological phenotype.

Authors:  Michael S Shawky; Cecilia W Huo; Kara Britt; Erik W Thompson; Michael A Henderson; Andrew Redfern
Journal:  Breast Cancer Res Treat       Date:  2019-06-08       Impact factor: 4.872

2.  Dose-dependent effect of mammographic breast density on the risk of contralateral breast cancer.

Authors:  Marzana Chowdhury; David Euhus; Maureen O'Donnell; Tracy Onega; Pankaj K Choudhary; Swati Biswas
Journal:  Breast Cancer Res Treat       Date:  2018-03-06       Impact factor: 4.872

3.  Is there an increasing trend of risk-reducing prophylactic mastectomy procedure in preventing breast cancer among women?

Authors:  Bilal Arslan; Deniz Tazeoğlu; Ahmet Dağ; Mustafa Berkeşoğlu; Asena Ayça Özdemir
Journal:  Turk J Surg       Date:  2021-12-31

Review 4.  Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature Review.

Authors:  Renée S J M Schmitz; Erica A Wilthagen; Frederieke van Duijnhoven; Marja van Oirsouw; Ellen Verschuur; Thomas Lynch; Rinaa S Punglia; E Shelley Hwang; Jelle Wesseling; Marjanka K Schmidt; Eveline M A Bleiker; Ellen G Engelhardt
Journal:  Cancers (Basel)       Date:  2022-07-02       Impact factor: 6.575

5.  PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.

Authors:  Daniele Giardiello; Maartje J Hooning; Michael Hauptmann; Renske Keeman; B A M Heemskerk-Gerritsen; Heiko Becher; Carl Blomqvist; Stig E Bojesen; Manjeet K Bolla; Nicola J Camp; Kamila Czene; Peter Devilee; Diana M Eccles; Peter A Fasching; Jonine D Figueroa; Henrik Flyger; Montserrat García-Closas; Christopher A Haiman; Ute Hamann; John L Hopper; Anna Jakubowska; Floor E Leeuwen; Annika Lindblom; Jan Lubiński; Sara Margolin; Maria Elena Martinez; Heli Nevanlinna; Ines Nevelsteen; Saskia Pelders; Paul D P Pharoah; Sabine Siesling; Melissa C Southey; Annemieke H van der Hout; Liselotte P van Hest; Jenny Chang-Claude; Per Hall; Douglas F Easton; Ewout W Steyerberg; Marjanka K Schmidt
Journal:  Breast Cancer Res       Date:  2022-10-21       Impact factor: 8.408

6.  Clinical characteristics and the associated risk factors of the development of bilateral breast cancers: A case-control study.

Authors:  Sumadi Lukman Anwar; Dayat Prabowo; Widya Surya Avanti; Ery Kus Dwianingsih; Wirsma Arif Harahap; Teguh Aryandono
Journal:  Ann Med Surg (Lond)       Date:  2020-11-04

7.  The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study.

Authors:  Julia A Knight; Kristina M Blackmore; Jing Fan; Kathleen E Malone; Esther M John; Charles F Lynch; Celine M Vachon; Leslie Bernstein; Jennifer D Brooks; Anne S Reiner; Xiaolin Liang; Meghan Woods; Jonine L Bernstein
Journal:  Breast Cancer Res       Date:  2018-03-22       Impact factor: 6.466

8.  Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer.

Authors:  Jia Jin; Yu Gao; Jian Zhang; Leiping Wang; Biyun Wang; Jun Cao; Zhimin Shao; Zhonghua Wang
Journal:  BMC Cancer       Date:  2018-04-19       Impact factor: 4.430

9.  Comparative Analysis of Outcomes and Clinicopathological Characteristics of Synchronous and Metachronous Contralateral Breast Cancer: A Study of the SEER Database.

Authors:  Ruiyue Qiu; Wen Zhao; Jiao Yang; Yanwei Shen; Biyuan Wang; Pan Li; Andi Zhao; Qi Tian; Mi Zhang; Min Yi; Jin Yang; Danfeng Dong
Journal:  J Breast Cancer       Date:  2019-04-03       Impact factor: 3.588

10.  Prediction and clinical utility of a contralateral breast cancer risk model.

Authors:  Daniele Giardiello; Ewout W Steyerberg; Michael Hauptmann; Muriel A Adank; Delal Akdeniz; Carl Blomqvist; Stig E Bojesen; Manjeet K Bolla; Mariël Brinkhuis; Jenny Chang-Claude; Kamila Czene; Peter Devilee; Alison M Dunning; Douglas F Easton; Diana M Eccles; Peter A Fasching; Jonine Figueroa; Henrik Flyger; Montserrat García-Closas; Lothar Haeberle; Christopher A Haiman; Per Hall; Ute Hamann; John L Hopper; Agnes Jager; Anna Jakubowska; Audrey Jung; Renske Keeman; Iris Kramer; Diether Lambrechts; Loic Le Marchand; Annika Lindblom; Jan Lubiński; Mehdi Manoochehri; Luigi Mariani; Heli Nevanlinna; Hester S A Oldenburg; Saskia Pelders; Paul D P Pharoah; Mitul Shah; Sabine Siesling; Vincent T H B M Smit; Melissa C Southey; William J Tapper; Rob A E M Tollenaar; Alexandra J van den Broek; Carolien H M van Deurzen; Flora E van Leeuwen; Chantal van Ongeval; Laura J Van't Veer; Qin Wang; Camilla Wendt; Pieter J Westenend; Maartje J Hooning; Marjanka K Schmidt
Journal:  Breast Cancer Res       Date:  2019-12-17       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.